Literature DB >> 21310961

Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate.

Xiaoqing Gan1, Jiyong Wang, Bing Su, Dianqing Wu.   

Abstract

mTORC2 (mammalian target of rapamycin complex 2) plays important roles in signal transduction by regulating an array of downstream effectors, including protein kinase AKT. However, its regulation by upstream regulators remains poorly characterized. Although phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P(3)) is known to regulate the phosphorylation of AKT Ser(473), the hydrophobic motif (HM) site, by mTORC2, it is not clear whether PtdIns(3,4,5)P(3) can directly regulate mTORC2 kinase activity. Here, we used two membrane-docked AKT mutant proteins, one with and the other without the pleckstrin homology (PH) domain, as substrates for mTORC2 to dissect the roles of PtdIns(3,4,5)P(3) in AKT HM phosphorylation in cultured cells and in vitro kinase assays. In HEK293T cells, insulin and constitutively active mutants of small GTPase H-Ras and PI3K could induce HM phosphorylation of both AKT mutants, which was blocked by the PI3K inhibitor LY294002. Importantly, PtdIns(3,4,5)P(3) was able to stimulate the phosphorylation of both AKT mutants by immunoprecipitated mTOR2 complexes in an in vitro kinase assay. In both in vivo and in vitro assays, the AKT mutant containing the PH domain appeared to be a better substrate than the one without the PH domain. Therefore, these results suggest that PtdIns(3,4,5)P(3) can regulate HM phosphorylation by mTORC2 via multiple mechanisms. One of the mechanisms is to directly stimulate the kinase activity of mTORC2.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21310961      PMCID: PMC3064154          DOI: 10.1074/jbc.M110.195016

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Robert R Latek; Kalyani V P Guntur; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

2.  Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.

Authors:  Kenta Hara; Yoshiko Maruki; Xiaomeng Long; Ken-ichi Yoshino; Noriko Oshiro; Sujuti Hidayat; Chiharu Tokunaga; Joseph Avruch; Kazuyoshi Yonezawa
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

3.  Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.

Authors:  Robbie Loewith; Estela Jacinto; Stephan Wullschleger; Anja Lorberg; José L Crespo; Débora Bonenfant; Wolfgang Oppliger; Paul Jenoe; Michael N Hall
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

4.  mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action.

Authors:  Ghada A Soliman; Hugo A Acosta-Jaquez; Elaine A Dunlop; Bilgen Ekim; Nicole E Maj; Andrew R Tee; Diane C Fingar
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

5.  Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells.

Authors:  F Tremblay; A Marette
Journal:  J Biol Chem       Date:  2001-08-09       Impact factor: 5.157

6.  Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling.

Authors:  Tsuneo Ikenoue; Ken Inoki; Qian Yang; Xiaoming Zhou; Kun-Liang Guan
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

7.  mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).

Authors:  Juan M García-Martínez; Dario R Alessi
Journal:  Biochem J       Date:  2008-12-15       Impact factor: 3.857

8.  TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2.

Authors:  Jeremy Copp; Gerard Manning; Tony Hunter
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

9.  Identification of a proline-rich Akt substrate as a 14-3-3 binding partner.

Authors:  Kristina S Kovacina; Grace Y Park; Sun Sik Bae; Andrew W Guzzetta; Erik Schaefer; Morris J Birnbaum; Richard A Roth
Journal:  J Biol Chem       Date:  2003-01-10       Impact factor: 5.157

10.  mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Jessie E King; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

View more
  102 in total

Review 1.  The "other" mTOR complex: New insights into mTORC2 immunobiology and their implications.

Authors:  Helong Dai; Angus W Thomson
Journal:  Am J Transplant       Date:  2019-03-19       Impact factor: 8.086

2.  O(2) regulates skeletal muscle progenitor differentiation through phosphatidylinositol 3-kinase/AKT signaling.

Authors:  Amar J Majmundar; Nicolas Skuli; Rickson C Mesquita; Meeri N Kim; Arjun G Yodh; Michelle Nguyen-McCarty; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

3.  Mechanical regulation of glycogen synthase kinase 3β (GSK3β) in mesenchymal stem cells is dependent on Akt protein serine 473 phosphorylation via mTORC2 protein.

Authors:  Natasha Case; Jacob Thomas; Buer Sen; Maya Styner; Zhihui Xie; Kornelia Galior; Janet Rubin
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

Review 4.  The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes.

Authors:  Jianling Xie; Terence P Herbert
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

5.  Regulatory effects of mTORC2 complexes in type I IFN signaling and in the generation of IFN responses.

Authors:  Surinder Kaur; Antonella Sassano; Beata Majchrzak-Kita; Darren P Baker; Bing Su; Eleanor N Fish; Leonidas C Platanias
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-01       Impact factor: 11.205

6.  Mechanically activated Fyn utilizes mTORC2 to regulate RhoA and adipogenesis in mesenchymal stem cells.

Authors:  William R Thompson; Christophe Guilluy; Zhihui Xie; Buer Sen; Kaitlyn E Brobst; Sherwin S Yen; Gunes Uzer; Maya Styner; Natasha Case; Keith Burridge; Janet Rubin
Journal:  Stem Cells       Date:  2013-11       Impact factor: 6.277

Review 7.  Regulation of mTORC1 by PI3K signaling.

Authors:  Christian C Dibble; Lewis C Cantley
Journal:  Trends Cell Biol       Date:  2015-07-06       Impact factor: 20.808

Review 8.  Differential T-cell receptor signals for T helper cell programming.

Authors:  Penelope A Morel
Journal:  Immunology       Date:  2018-05-25       Impact factor: 7.397

9.  XPLN is an endogenous inhibitor of mTORC2.

Authors:  Nidhi Khanna; Yimin Fang; Mee-Sup Yoon; Jie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

10.  Alternative Activation Mechanisms of Protein Kinase B Trigger Distinct Downstream Signaling Responses.

Authors:  Deborah Balzano; Mohamad-Ali Fawal; Jose V Velázquez; Clara M Santiveri; Joshua Yang; Joaquín Pastor; Ramón Campos-Olivas; Nabil Djouder; Daniel Lietha
Journal:  J Biol Chem       Date:  2015-08-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.